Cancer Research Roundup: Deciphering Keys to Cancer Response Kicks Off National Cancer Research Month

May 2, 2014

All of the key advances made in the prevention, detection, and treatment of cancer have all been possible through significant investment in cancer research. To celebrate May as National Cancer Research Month, we will highlight the breadth of research by University of Chicago Medicine Comprehensive Cancer Center investigators and show how our patients have directly benefited from broad investment in cancer research. [Read more]

January Brings Important Attention to Cervical Cancer

January 30, 2014

January is Cervical Health Awareness Month, providing the opportunity to turn the spotlight on issues related to cervical cancer, its link to human papillomavirus (HPV), and the importance of early detection. Cervical cancer is one of the most preventable cancers because of readily available screening tests, including the Pap smear and HPV testing. Despite screening and prevention efforts, approximately 12,000 women each year will be newly diagnosed with cervical cancer in the US. [Read more]

A Big Leap for Neuroblastoma

September 30, 2010

Cancer successes are usually measured in months, not years. Large clinical trial on promising new treatments are celebrated when they show an average effect of a dozen weeks, and extension of life that can be measured in years is cause for rapture. [Read more]

Q&A: A New Kind of Cancer Vaccine

May 19, 2010

At the end of April, an FDA approval marked the end of a long regulatory road for an interesting drug with an even more interesting history: Provenge. Though it’s usually described as a vaccine for metastatic prostate cancer, that terminology [Read more]